The Detection of Novelty Relies on Dopaminergic Signaling: Evidence from Apomorphine's Impact on the Novelty N2

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Rangel Gomez, Mauricio ^a   Hickey, Clayton ^a   van Amelsvoort, Therese ^b   Bet, Pierre ^c   Meeter, Martijn ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

APOMORPHINE; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; PLACEBO;

ADULT; ARTICLE; COGNITION; CONTROLLED STUDY; ELECTROENCEPHALOGRAPHY; EVENT RELATED POTENTIAL; FEMALE; HUMAN; HUMAN EXPERIMENT; INFORMATION PROCESSING; MALE; NORMAL HUMAN; NOVELTY DETECTION; RECALL; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; STIMULUS RESPONSE; TASK PERFORMANCE; VISUAL STIMULATION; VOLUNTEER; WORD RECOGNITION;

ADOLESCENT; ADULT; APOMORPHINE; DOPAMINE AGONISTS; DOPAMINERGIC NEURONS; DOUBLE-BLIND METHOD; EVENT-RELATED POTENTIALS, P300; EVOKED POTENTIALS, VISUAL; FEMALE; HUMANS; MALE; PHOTIC STIMULATION; SIGNAL TRANSDUCTION; YOUNG ADULT;

EID: 84879258124     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0066469     Document Type: Article

References (59)

1. Ranganath C, Rainer G, (2003) Neural mechanisms for detecting and remembering novel events. Nat Rev Neurosci 4: 193-202.
2. Pritchard W, Shappell S, Brandt M (1991) Psychophysiology of N200/N400: A review and classification scheme. In: Jennings J, Ackles P, editors. Advances in psychophysiology: A research annual. London: Jessica Kingsley. 43-106.
3. Spencer KM, Dien J, Donchin E, (1999) A componential analysis of the ERP elicited by novel events using a dense electrode array. Psychophysiology 36: 409-414.
4. Squires NK, Squires KC, Hillyard SA, (1975) Two varieties of long-latency positive waves evoked by unpredictable auditory stimuli in man. Electroencephalogr Clin Neurophysiol 38: 387-401.
5. Daffner KR, Mesulam MM, Scinto LF, Calvo V, Faust R, et al. (2000) An electrophysiological index of stimulus unfamiliarity. Psychophysiology 37: 737-747.
6. Tarbi EC, Sun X, Holcomb PJ, Daffner KR, (2010) Surprise? Early visual novelty processing is not modulated by attention. Psychophysiology 48: 624-632.
7. Ferrari V, Bradley MM, Codispoti M, Lang PJ, (2010) Detecting novelty and significance. J Cogn Neurosci 22: 404-411.
8. Folstein JR, Van Petten C, (2008) Influence of cognitive control and mismatch on the N2 component of the ERP: a review. Psychophysiology 45: 152-170.
9. Kujala T, Kallio J, Tervaniemi M, Naatanen R, (2001) The mismatch negativity as an index of temporal processing in audition. Clin Neurophysiol 112: 1712-1719.
10. Alho K, Woods DL, Algazi A, (1994) Processing of auditory stimuli during auditory and visual attention as revealed by event-related potentials. Psychophysiology 31: 469-479.
11. Szucs D, Soltesz F, Czigler I, Csepe V, (2007) Electroencephalography effects to semantic and non-semantic mismatch in properties of visually presented single-characters: the N2b and the N400. Neuroscience letters 412: 18-23.
12. Crottaz-Herbette S, Menon V, (2006) Where and when the anterior cingulate cortex modulates attentional response: combined fMRI and ERP evidence. Journal of cognitive neuroscience 18: 766-780.
13. Kopp B, Wessel K, (2010) Event-related brain potentials and cognitive processes related to perceptual-motor information transmission. Cognitive, affective & behavioral neuroscience 10: 316-327.
14. Friedman D, Cycowicz YM, Gaeta H, (2001) The novelty P3: an event-related brain potential (ERP) sign of the brain's evaluation of novelty. Neurosci Biobehav Rev 25: 355-373.
15. SanMiguel I, Morgan HM, Klein C, Linden D, Escera C, (2010) On the functional significance of Novelty-P3: facilitation by unexpected novel sounds. Biol Psychol 83: 143-152.
16. Courchesne E, Hillyard SA, Galambos R, (1975) Stimulus novelty, task relevance and the visual evoked potential in man. Electroencephalogr Clin Neurophysiol 39: 131-143.
17. Soltani M, Knight RT, (2000) Neural origins of the P300. Critical reviews in neurobiology 14: 199-224.
18. Gabbay FH, Duncan CC, McDonald CG, (2010) Brain potential indices of novelty processing are associated with preference for amphetamine. Experimental and clinical psychopharmacology 18: 470-488.
19. Grzella I, Muller BW, Oades RD, Bender S, Schall U, et al. (2001) Novelty-elicited mismatch negativity in patients with schizophrenia on admission and discharge. Journal of psychiatry & neuroscience: JPN 26: 235-246.
20. Djamshidian A, O'Sullivan SS, Wittmann BC, Lees AJ, Averbeck BB, (2011) Novelty seeking behaviour in Parkinson's disease. Neuropsychologia 49: 2483-2488.
21. Wittmann BC, Bunzeck N, Dolan RJ, Duzel E, (2007) Anticipation of novelty recruits reward system and hippocampus while promoting recollection. Neuroimage 38: 194-202.
22. Garcia-Garcia M, Barcelo F, Clemente IC, Escera C, (2011) COMT and ANKK1 gene-gene interaction modulates contextual updating of mental representations. Neuroimage 56: 1641-1647.
23. Garcia-Garcia M, Barcelo F, Clemente IC, Escera C, (2010) The role of DAT1 gene on the rapid detection of task novelty. Neuropsychologia 48: 4136-4141.
24. Polich J, Criado JR, (2006) Neuropsychology and neuropharmacology of P3a and P3b. Int J Psychophysiol 60: 172-185.
25. Polich J, (2007) Updating P300: an integrative theory of P3a and P3b. Clin Neurophysiol 118: 2128-2148.
26. Kenemans JL, Kahkonen S, (2011) How Human Electrophysiology Informs Psychopharmacology: from Bottom-up Driven Processing to Top-Down Control. Neuropsychopharmacology 36: 26-51.
27. Redgrave P, Gurney K, (2006) The short-latency dopamine signal: a role in discovering novel actions? Nat Rev Neurosci 7: 967-975.
28. Hazy TE, Frank MJ, O'Reilly RC, (2010) Neural mechanisms of acquired phasic dopamine responses in learning. Neurosci Biobehav Rev 34: 701-720.
29. Ruzicka E, Roth J, Spackova N, Mecir P, Jech R, (1994) Apomorphine induced cognitive changes in Parkinson's disease. J Neurol Neurosurg Psychiatry 57: 998-1001.
30. Nakamura K, Kurasawa M, Tanaka Y, (1998) Apomorphine-induced hypoattention in rats and reversal of the choice performance impairment by aniracetam. Eur J Pharmacol 342: 127-138.
31. Von Restorff H, (1933) Über die Wirkung von Bereichsbildungen im Spurenfeld [The effects of field formation in the trace field]. Psychologie Forschung 18: 299-234.
32. Kishiyama MM, Yonelinas AP, Lazzara MM, (2004) The von Restorff effect in amnesia: the contribution of the hippocampal system to novelty-related memory enhancements. Journal of cognitive neuroscience 16: 15-23.
33. Meeter M, Talamini LM, Murre JMJ, (2004) Mode shifting between storage and recall based on novelty detection in oscillating hippocampal circuits. Hippocampus 14: 722-741.
34. Hasselmo ME, Bradley P, Wyble BP, Wallenstein GV, (1996) Encoding and retrieval of episodic memories: Role of cholinergic and GABAergic modulation in the hippocampus. Hippocampus 6: 693-708.
35. Kiesel A, Miller J, Jolicoeur P, Brisson B, (2008) Measurement of ERP latency differences: a comparison of single-participant and jackknife-based scoring methods. Psychophysiology 45: 250-274.
36. Hoormann J, Falkenstein M, Schwarzenau P, Hohnsbein J, (1998) Methods for the quantification and statistical testing of ERP differences across conditions. Behavior Research Methods Instruments & Computers 30: 103-109.
37. Tulving E, Markowitsch HJ, Craik FE, Habib R, Houle S, (1996) Novelty and familiarity activations in PET studies of memory encoding and retrieval. Cereb Cortex 6: 71-79.
38. Barcelo F, Knight RT, (2007) An information-theoretical approach to contextual processing in the human brain: evidence from prefrontal lesions. Cereb Cortex 17Suppl 1: i51-60.
39. Takeshita S, Ogura C, (1994) Effect of the dopamine D2 antagonist sulpiride on event-related potentials and its relation to the law of initial value. International journal of psychophysiology 16: 99-106.
40. Albrecht MA, Martin-Iverson MT, Price G, Lee J, Iyyalol R (2010) Dexamphetamine-induced reduction of P3a and P3b in healthy participants. Journal of psychopharmacology.
41. Prasher D, Findley L, (1991) Dopaminergic induced changes in cognitive and motor processing in Parkinson's disease: an electrophysiological investigation. Journal of neurology, neurosurgery, and psychiatry 54: 603-609.
42. Garcia-Garcia M, Clemente I, Dominguez-Borras J, Escera C, (2010) Dopamine transporter regulates the enhancement of novelty processing by a negative emotional context. Neuropsychologia 48: 1483-1488.
43. Rangel-Gomez M, Meeter M (2013) Electrophysiological analysis of the role of novelty in the von Restorff Effect. Brain and Behavior.
44. Potts GF, Liotti M, Tucker DM, Posner MI, (1996) Frontal and inferior temporal cortical activity in visual target detection: Evidence from high spatially sampled event-related potentials. Brain Topography 9: 3-14.
45. Näätänen R, Gaillard AWK, Mäntysalo S, (1978) Early selective-attention effect on evoked potential reinterpreted. Acta Psychologica 42: 313-329.
46. Naatanen R, Gaillard AW, Mantysalo S, (1980) Brain potential correlates of voluntary and involuntary attention. Prog Brain Res 54: 343-348.
47. Hansenne M, Pinto E, Scantamburlo G, Couvreur A, Reggers J, et al. (2003) Mismatch negativity is not correlated with neuroendocrine indicators of catecholaminergic activity in healthy subjects. Human Psychopharmacology-Clinical and Experimental 18: 201-205.
48. Kimura M, Schroger E, Czigler I, (2011) Visual mismatch negativity and its importance in visual cognitive sciences. Neuroreport 22: 669-673.
49. Kellendonk C, Simpson EH, Polan HJ, Malleret G, Vronskaya S, et al. (2006) Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning. Neuron 49: 603-615.
50. Li YC, Kellendonk C, Simpson EH, Kandel ER, Gao WJ, (2011) D2 receptor overexpression in the striatum leads to a deficit in inhibitory transmission and dopamine sensitivity in mouse prefrontal cortex. Proc Natl Acad Sci U S A 108: 12107-12112.
51. Costa A, Peppe A, Dell'Agnello G, Carlesimo GA, Murri L, et al. (2003) Dopaminergic modulation of visual-spatial working memory in Parkinson's disease. Dement Geriatr Cogn Disord 15: 55-66.
52. Schellekens AF, Grootens KP, Neef C, Movig KL, Buitelaar JK, et al. (2010) Effect of apomorphine on cognitive performance and sensorimotor gating in humans. Psychopharmacology (Berl) 207: 559-569.
53. Bunzeck N, Düzel E, (2006) Absolute coding of stimulus novelty in the human Substantia Nigra/VTA. Neuron 51: 369-379.
54. Pirtosek Z, (2009) 'Bad guys' among the antiparkinsonian drugs. Psychiatr Danub 21: 114-118.
55. Schellekens AF, van Oosterwijck AW, Ellenbroek B, de Jong CA, Buitelaar JK, et al. (2009) The dopamine agonist apomorphine differentially affects cognitive performance in alcohol dependent patients and healthy controls. Eur Neuropsychopharmacol 19: 68-73.
56. Van Overschelde JP, Rawson KA, Dunlosky J, (2004) Category norms: An updated and expanded version of the Battig and Montague (1969) norms. Journal of Memory and Language 50: 289-335.
57. Delorme A, Makeig S, (2004) EEGLAB: an open source toolbox for analysis of single-trial EEG dynamics including independent component analysis. J Neurosci Methods 134: 9-21.
58. Delorme A, Sejnowski T, Makeig S, (2007) Enhanced detection of artifacts in EEG data using higher-order statistics and independent component analysis. Neuroimage 34: 1443-1449.
59. Jung TP, Makeig S, Westerfield M, Townsend J, Courchesne E, et al. (2000) Removal of eye activity artifacts from visual event-related potentials in normal and clinical subjects. Clin Neurophysiol 111: 1745-1758.